BioCardia (BCDA) Gross Profit Growth (3y) (2016 - 2021)
Powered by 
Analysis
BioCardia (BCDA) Gross Profit Growth (3y) (2016 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 219.94% |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 83.57% |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 3.51% |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 23.50% |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 100.64% |
| Sep 30, 2021 | 226.61% |
| Jun 30, 2021 | -12.78% |
| Dec 31, 2020 | 39.38% |
| Sep 30, 2020 | 58.74% |
| Jun 30, 2020 | 31.94% |
| Mar 31, 2020 | 42.52% |
| Dec 31, 2019 | 97.83% |
| Sep 30, 2019 | 60.72% |
| Jun 30, 2019 | -106.06% |
| Mar 31, 2019 | 62.51% |
| Jun 30, 2016 | -29.54% |
| Mar 31, 2016 | -48.32% |